Wound Healing Following Extraction and Ridge Preservation in Smokers and Non-smokers

January 20, 2026 updated by: Vrisiis Kofina, Marquette University
The goal of this study is to evaluate bone wound healing following extraction and alveolar ridge preservation (bone graft and membrane) clinically, histologically and in relation to gene expression in smokers and non-smokers. Data from a small group of participants will be analyzed after age-matched subjects undergo extraction and alveolar ridge preservation prior to implant placement. The data obtained in this pilot study will be used to plan a full-fledged study involving a larger number of smoking and non-smoking participants to compare the two groups.

Study Overview

Detailed Description

All research procedures will start after IRB approval. Patients of the Graduate Periodontics Clinic in need of extraction, bone graft and membrane will be recruited. There will be two groups (smokers and non-smokers) and their demographic and social, periodontal, surgery-related, anatomical and healing variables as well as patient-reported outcomes will be recorded at different time points (immediately before, during and immediately after surgery and 1, 2, 6 weeks and 4 months) in order to evaluate wound healing outcomes and differences between the groups. The demographic and social variables evaluated are age, gender, race, medical history, medications, smoking (via interview and breath test-smokerlyzer) and alcohol consumption (via interview). The periodontal variables are tooth mobility, probing depth, attachment level, gingival and plaque index. The surgery-related variables include intraoperative complications, duration of procedure, anesthetic amount, type and approach and operator experience. The anatomical variables are bone height and width (buccolingual and buccal dimension), bone density (in Cone Beam Computed Tomographies - CBCTs) and gingival width and thickness. The healing variables include wound opening (tested clinically and in photos), bleeding, grafting material discharge, flap necrosis, loose sutures, and temporary restoration adjustment. The patient-reported outcomes are Oral Health Impact Questionnaire-14 (OHIP-14), Visual Analogue Scale (VAS) for pain, swelling and difficulty of mouth opening. At 4 months during the implant placement appointment, a bone core will be harvested via a 3D printed surgical guide based on virtual CBCT planning. The core willl be used of microCT and histological analysis as well as total RNA extraction and RNA sequencing.

Study Type

Observational

Enrollment (Estimated)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53233
        • Marquette University School of Dentistry Graduate Periodontics Clinic
        • Contact:
        • Contact:
        • Principal Investigator:
          • Vrisiis Kofina, DDS, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for tooth extraction and alveolar ridge preservation (bone graft and membrane) in the Graduate Periodontics Clinic at Marquette University School of Dentistry.

Description

Inclusion Criteria:

  • Adult patients (18-75 years)
  • Good general health (controlled conditions)
  • Smokers (≥10 cigarettes/day for ≥5 years) and never smokers. Confirmation of smoking status will be done via use of a smokerlyzer. The cut-off point for distinguishing smokers from non-smokers is 8 carbon monoxide parts per million (ppm).
  • Periodontal status: periodontal health, gingivitis on intact or reduced periodontium, treated periodontitis
  • Intact post-extraction bony walls or less than 50% bone dehiscence
  • Distance at least 8 mm of vertical bone height between bone crest and anatomical structures (i.e. sinus floor, inferior alveolar nerve (IAN) canal, mental foramen)
  • Extracted tooth root in the same three-dimensional position as the future implant placement so that the bone core biopsy can be taken from a site totally within the confines of the former tooth socket without inclusion of surrounding native alveolar bone
  • Scheduled for single tooth extraction with bone graft placement and membrane

Exclusion Criteria:

  • Uncontrolled periodontal disease
  • Uncontrolled systemic disease
  • Pregnancy
  • Use of therapy and/or medication that impairs wound healing (e.g., bisphosphonates, steroids, chemotherapy, radiotherapy etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Smokers
Subjects are qualified as smokers if they report smoking ≥10 cigarettes/day for ≥5 years, and maintain a 8ppm carbon monoxide concentration or higher via smokerlyzer test.
Observational study; alveolar ridge preservation
Non-smokers
Subjects qualify as nonsmokers if they have never smoked and upon confirmation by the smokerlyzer test of carbon monoxide concentation of less than 8ppm.
Observational study; alveolar ridge preservation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Parameters
Time Frame: Measured before surgery, during surgery and at 4 months
bone width
Measured before surgery, during surgery and at 4 months
Clinical Parameters
Time Frame: Measured before surgery, during surgery and at 4 months
bone height
Measured before surgery, during surgery and at 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genetic Parameters
Time Frame: Bone samples harvested at 4 months
RNA transcriptomic analysis
Bone samples harvested at 4 months
Histological Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: %mineralized bone
Samples harvested at 4 months
Histological Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: %osteoid
Samples harvested at 4 months
Histological Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: %residual bone graft
Samples harvested at 4 months
Histological Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: %soft tissue
Samples harvested at 4 months
Histological Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: numbers of osteoblasts and osteoclasts
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: bone mineral density
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: tissue mineral density
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: bone volume / tissue volume (BV/TV)
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: trabecular number
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: trabecular separation
Samples harvested at 4 months
Micro-CT Parameters
Time Frame: Samples harvested at 4 months
Histological analysis of bone cores: trabecular thickness
Samples harvested at 4 months
Patient-reported Parameters
Time Frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months
Oral Health Impact Profile -14 (OHIP-14). Range from 0 (no impact) to 56 (most severe impact).
Measured before surgery, at 1, 2 and 6 weeks, and 4 months
Patient-reported Parameters
Time Frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months
VAS for pain (0-100). Zero indicates no pain and 100 the worst pain imaginable.
Measured before surgery and at 1, 2 and 6 weeks, and 4 months
Patient-reported Parameters
Time Frame: Measured before surgery and at 1, 2 and 6 weeks, and 4 months
VAS for swelling (0-100). Zero indicates no swelling and 100 the worst swelling imaginable.
Measured before surgery and at 1, 2 and 6 weeks, and 4 months
Patient-reported Parameters
Time Frame: Measured before surgery, at 1, 2 and 6 weeks, and 4 months
VAS for difficulty of mouth opening (0-100). Zero indicates no difficulty of mouth opening and 100 complete inability to open mouth.
Measured before surgery, at 1, 2 and 6 weeks, and 4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Parameters
Time Frame: Measured at baseline (before surgery)
gingival width
Measured at baseline (before surgery)
Clinical Parameters
Time Frame: Measured at baseline (before surgery)
gingival thickness
Measured at baseline (before surgery)
Clinical Parameters
Time Frame: Measured immediately after surgery, at 1, 2 and 6 weeks and 4 months
wound opening
Measured immediately after surgery, at 1, 2 and 6 weeks and 4 months
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
bleeding
Measured at 1, 2 and 6 weeks and 4 months
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
grafting material discharge
Measured at 1, 2 and 6 weeks and 4 months
Clinical Parameters
Time Frame: Measured at 1, 2 and 6 weeks and 4 months
flap necrosis
Measured at 1, 2 and 6 weeks and 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Vrisiis Kofina, DDS, MS, Marquette University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 25, 2026

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

October 1, 2028

Study Registration Dates

First Submitted

December 2, 2025

First Submitted That Met QC Criteria

January 20, 2026

First Posted (Actual)

January 28, 2026

Study Record Updates

Last Update Posted (Actual)

January 28, 2026

Last Update Submitted That Met QC Criteria

January 20, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HR-4728

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wound Healing

Clinical Trials on observational study

Subscribe